Fresenius Medical Care AG & Co. KGaA
FMS · NYSE
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.33 | 0.18 | -0.73 | 0.94 |
| FCF Yield | 4.36% | 0.13% | 7.85% | 5.75% |
| EV / EBITDA | 28.62 | 31.42 | 82.29 | 24.92 |
| Quality | ||||
| ROIC | 1.21% | 0.88% | 0.59% | 1.13% |
| Gross Margin | 25.34% | 24.25% | 24.99% | 24.08% |
| Cash Conversion Ratio | 2.70 | 2.85 | 0.86 | 12.43 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.31% | -0.18% | -0.10% | -0.11% |
| Free Cash Flow Growth | 3,536.59% | -98.37% | 61.83% | 132.65% |
| Safety | ||||
| Net Debt / EBITDA | 11.32 | 13.19 | 34.96 | 11.65 |
| Interest Coverage | 4.40 | 3.46 | 2.57 | 4.66 |
| Efficiency | ||||
| Inventory Turnover | 1.79 | 1.78 | 1.84 | 1.72 |
| Cash Conversion Cycle | 92.00 | 95.02 | 85.91 | 95.05 |